Tiziana Life Sciences Ltd. Common Shares (TLSA)
TLSA trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.09
0.00% on the day
Market cap
$138.7M
Micro cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | TLSA on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United Kingdom |
| IPO year | 2018 |
| SEC CIK | 0001723069 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | D0 |
Financials
Foreign filer: no machine-readable annual figure in SEC data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS SUPPLEMENT | 424B5 | 2026-01-22 |
| Latest annual report ANNUAL REPORT | 20-F | 2026-05-01 |
| Latest quarterly / interim REPORT OF FOREIGN PRIVATE ISSUER | 6-K | 2026-09-30 |
Source: SEC EDGAR submissions feed, 486 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| BGM | BGM Group Ltd. | $10.48 | +2.75% | $140.0M |
| ANTX | AN2 Therapeutics Inc. | $3.60 | -16.28% | $135.9M |
| ALXO | ALX Oncology Holdings Inc. | $0.9796 | -22.25% | $135.5M |
| CUE | Cue Biopharma Inc. | $19.57 | -20.48% | $142.2M |
| RNA | Atrium Therapeutics Inc. | $7.75 | -5.60% | $132.6M |
| KRRO | Korro Bio Inc. | $8.81 | -5.98% | $129.7M |
| OGI | Organigram Global Inc. Common Shares | $0.9190 | -1.68% | $129.6M |
| NBP | NovaBridge Biosciences | $1.29 | -2.27% | $148.8M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier